CEND-1: a game changer for pancreatic cancer chemotherapy?

Lancet Gastroenterol Hepatol. 2022 Oct;7(10):900-902. doi: 10.1016/S2468-1253(22)00197-2. Epub 2022 Jul 6.

Authors

Christoph Springfeld¹, John P Neoptolemos²

Affiliations

¹ Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, 69120 Heidelberg, Germany.
² Department of General Visceral and Transplantation Surgery, Heidelberg University Hospital, 69120 Heidelberg, Germany. Electronic address: john.neoptolemos@med.uni-heidelberg.de.

PMID: 35803295
DOI: 10.1016/S2468-1253(22)00197-2

No abstract available

Publication types

Comment

MeSH terms

Humans
Pancreatic Neoplasms* / drug therapy